Bullock Wealth Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Bullock Wealth Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,443	Closed	-$30.9K	–	611
2026 Q1	$30.9K	Hold	1,443	–	–	0.02%	314
2025 Q4	$13.4K	Buy	+1,443	New	+$12.1K	0.01%	375

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bullock Wealth Management's DAWN Position: Q2 2026 in Review

Bullock Wealth Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,443 shares — an estimated $30.9K sold.

Bullock Wealth Management first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $30.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Bullock Wealth Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Bullock Wealth Management sold 1,443 Day One Biopharmaceuticals shares in Q2 2026, an estimated $30.9K.
Bullock Wealth Management first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
Bullock Wealth Management's Day One Biopharmaceuticals position peaked at $30.9K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.